Skip to content
IP + Technology Law
Home  »  News & Insights  »  News  »  Media Mention

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight

March 3, 2016  | Michael L. Fuller

Partners Eli Loots, Ph.D. and Mike Fuller were interviewed for the article “Biosimilars could follow route of authorised generics though technical, market hurdles draw timeline uncertainty” in BioPharm Insight. 

Read the full article on the BioPharm Insight website >> (Subscription required)

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight Headshot

Michael L. Fuller
Partner
San Diego
mike.fuller@knobbe.com
858-707-4000

Related Links

Industries

News & Insights

News
Aug 2026
Five Knobbe Martens Partners Recognized in Benchmark Litigation “40 & Under” Guide
IRVINE, Calif., August 27, 2026 – Knobbe Martens is proud to share that five of the firm’s partners were named in the 2026 edition of Benchmark Litigation’s “40 & Under”...
News
Sep 2026
Knobbe Martens Announces Arrival of 2026 Fall Associate Class
IRVINE, Calif., September 14, 2026 – Knobbe Martens proudly welcomes 23 talented first-year associates to its offices across the country today, demonstrating the firm’s commitment to developing the next generation...
News
Sep 2026
IAM Quotes Sheila Swaroop on the Impact of a Fully Staffed ITC
In a recent IAM article, “Full US ITC bench could bring greater scrutiny and steadier precedent” Sheila Swaroop, co-chair of Knobbe Martens’ International Trade Commission Litigation practice, discussed how a...